Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP

• Published in: European journal of nutrition 2022-06, Vol.61 (4), p.1905-1918
• Main Authors: Genovese, Massimo, Luti, Simone, Pardella, Elisa, Vivoli-Vega, Mirella, Pazzagli, Luigia, Parri, Matteo, Caselli, Anna, Cirri, Paolo, Paoli, Paolo
• Format: Article
• Language: English
• Subjects: Antidiabetics; Chemistry; Chemistry and Materials Science; Diabetes; Diabetes mellitus; Enzymatic activity; Enzyme Inhibitors - chemistry; Enzyme Inhibitors - pharmacology; Epigallocatechin gallate; Gas chromatography; Hepatocytes; Humans; Insulin; Insulin - metabolism; Insulin Resistance; Kinases; Liver; Mass spectroscopy; Nutrition; Original Contribution; Phosphatase; Plant Extracts - chemistry; Plant Extracts - pharmacology; Protein-tyrosine-phosphatase; Proteins; Receptor, Insulin - metabolism; Signal Transduction; Tea; Tyrosine
• ISSN: 1436-6207; 1436-6215
• DOI: 10.1007/s00394-021-02776-w

Purpose The impact of tea constituents on the insulin-signaling pathway as well as their antidiabetic activity are still debated questions. Previous studies suggested that some tea components act as Protein Tyrosine Phosphatase 1B (PTP1B) inhibitors. However, their nature and mechanism of action remain to be clarified. This study aims to evaluate the effects of both tea extracts and some of their constituents on two main negative regulators of the insulin-signaling pathway, Low-Molecular-Weight Protein Tyrosine Phosphatase (LMW-PTP) and PTP1B. Methods The effects of cold and hot tea extracts on the enzyme activity were evaluated through in vitro assays. Active components were identified using gas chromatography—mass spectrometry (GC–MS) analysis. Finally, the impact of both whole tea extracts and specific active tea components on the insulin-signaling pathway was evaluated in liver and muscle cells. Results We found that both cold and hot tea extracts inhibit LMW-PTP and PTP1B, even if with a different mechanism of action. We identified galloyl moiety-bearing catechins as the tea components responsible for this inhibition. Specifically, kinetic and docking analyses revealed that epigallocatechin gallate (EGCG) is a mixed-type non-competitive inhibitor of PTP1B, showing an IC 50 value in the nanomolar range. Finally, in vitro assays confirmed that EGCG acts as an insulin-sensitizing agent and that the chronic treatment of liver cells with tea extracts results in an enhancement of the insulin receptor levels and insulin sensitivity. Conclusion Altogether, our data suggest that tea components are able to regulate both protein levels and activation status of the insulin receptor by modulating the activity of PTP1B.